These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 22785335

  • 21. Prompt efficacy of tolvaptan in treating hyponatremia of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) closely associated with rupture of a gastric artery aneurysm.
    Yamashita T, Yoshida M, Yamada H, Asano T, Aoki A, Ikoma A, Kusaka I, Kakei M, Ishikawa SE.
    Intern Med; 2014; 53(8):845-9. PubMed ID: 24739604
    [Abstract] [Full Text] [Related]

  • 22. Effectiveness and Tolerability of Conivaptan and Tolvaptan for the Treatment of Hyponatremia in Neurocritically Ill Patients.
    Der-Nigoghossian C, Lesch C, Berger K.
    Pharmacotherapy; 2017 May; 37(5):528-534. PubMed ID: 28295447
    [Abstract] [Full Text] [Related]

  • 23. Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience.
    Park GH, Lee CM, Song JW, Jung MC, Kim JK, Song YR, Kim HJ, Kim SG.
    Korean J Intern Med; 2018 May; 33(3):561-567. PubMed ID: 28286940
    [Abstract] [Full Text] [Related]

  • 24. SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan.
    De Las Peñas R, Ponce S, Henao F, Camps Herrero C, Carcereny E, Escobar Álvarez Y, Rodríguez CA, Virizuela JA, López López R.
    Support Care Cancer; 2016 Jan; 24(1):499-507. PubMed ID: 26431960
    [Abstract] [Full Text] [Related]

  • 25. Employment of vasopressin receptor antagonists in management of hyponatraemia and volume overload in some clinical conditions.
    Urso C, Brucculeri S, Caimi G.
    J Clin Pharm Ther; 2015 Aug; 40(4):376-85. PubMed ID: 25924179
    [Abstract] [Full Text] [Related]

  • 26. Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.
    Gargani L, Schmidt PH, Gheorghiade M.
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1505-13. PubMed ID: 22103869
    [Abstract] [Full Text] [Related]

  • 27. [A case of venlafaxine-induced syndrome of inappropriate ADH secretion (SIADH) - treatment with tolvaptan].
    Meyer I, Frank D, Janssens U.
    Dtsch Med Wochenschr; 2012 May; 137(21):1096-9. PubMed ID: 22588654
    [Abstract] [Full Text] [Related]

  • 28. Open-label, multicenter, dose-titration study to determine the efficacy and safety of tolvaptan in Japanese patients with hyponatremia secondary to syndrome of inappropriate secretion of antidiuretic hormone.
    Arima H, Goto K, Motozawa T, Mouri M, Watanabe R, Hirano T, Ishikawa SE.
    Endocr J; 2021 Jan 28; 68(1):17-29. PubMed ID: 32863282
    [Abstract] [Full Text] [Related]

  • 29. Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis.
    Indirli R, Ferreira de Carvalho J, Cremaschi A, Mantovani B, Sala E, Serban AL, Locatelli M, Bertani G, Carosi G, Fiore G, Tariciotti L, Arosio M, Mantovani G, Ferrante E.
    Front Endocrinol (Lausanne); 2021 Jan 28; 12():689887. PubMed ID: 34108941
    [Abstract] [Full Text] [Related]

  • 30. Utility and safety of tolvaptan in cirrhotic patients with hyponatremia: A prospective cohort study.
    Jia JD, Xie W, Ding HG, Mao H, Guo H, Li Y, Wang X, Wang JF, Lu W, Li CZ, Mao Y, Wang GQ, Gao YQ, Wang B, Zhang Q, Ge Y, Wong VW.
    Ann Hepatol; 2017 Jan 28; 16(1):123-132. PubMed ID: 28051801
    [Abstract] [Full Text] [Related]

  • 31. Clinical Experience of the Efficacy and Safety of Low-dose Tolvaptan Therapy in a UK Tertiary Oncology Setting.
    Chatzimavridou-Grigoriadou V, Al-Othman S, Brabant G, Kyriacou A, King J, Blackhall F, Trainer PJ, Higham CE.
    J Clin Endocrinol Metab; 2021 Oct 21; 106(11):e4766-e4775. PubMed ID: 33693944
    [Abstract] [Full Text] [Related]

  • 32. Therapeutic potential of vasopressin receptor antagonists.
    Ali F, Guglin M, Vaitkevicius P, Ghali JK.
    Drugs; 2007 Oct 21; 67(6):847-58. PubMed ID: 17428103
    [Abstract] [Full Text] [Related]

  • 33. Clinical review: the use of vaptans in clinical endocrinology.
    Peri A.
    J Clin Endocrinol Metab; 2013 Apr 21; 98(4):1321-32. PubMed ID: 23401044
    [Abstract] [Full Text] [Related]

  • 34. [Vasopressin antagonists in treatment of hyponatremia].
    Olszewski W, Głuszek J.
    Pol Arch Med Wewn; 2007 Aug 21; 117(8):356-62. PubMed ID: 18018383
    [Abstract] [Full Text] [Related]

  • 35. [Effectiveness and adequacy of tolvaptan prescription in hospitalized patients].
    Edo Solsona MD, Ruiz Ramos J, Montero Hernández M, Font Noguera I, Poveda Andrés JL.
    Farm Hosp; 2013 Aug 21; 37(3):178-81. PubMed ID: 23789795
    [Abstract] [Full Text] [Related]

  • 36. Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations.
    Jahangiri A, Wagner J, Tran MT, Miller LM, Tom MW, Kunwar S, Blevins L, Aghi MK.
    J Neurosurg; 2013 Dec 21; 119(6):1478-83. PubMed ID: 23971964
    [Abstract] [Full Text] [Related]

  • 37. Low-dose tolvaptan PK/PD: comparison of patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion to healthy adults.
    Shoaf SE, Bricmont P, Dandurand A.
    Eur J Clin Pharmacol; 2017 Nov 21; 73(11):1399-1408. PubMed ID: 28803333
    [Abstract] [Full Text] [Related]

  • 38. Tolvaptan for SIADH in Myelodysplastic Syndrome with Blast Crisis.
    Mali P, Muduganti SR, Mujibur R, Murali N.
    WMJ; 2015 Apr 21; 114(2):66-8. PubMed ID: 26756059
    [Abstract] [Full Text] [Related]

  • 39. Syndrome of inappropriate secretion of antidiuretic hormone in traumatic brain injury: when tolvaptan becomes a life saving drug.
    Graziani G, Cucchiari D, Aroldi A, Angelini C, Gaetani P, Selmi C.
    J Neurol Neurosurg Psychiatry; 2012 May 21; 83(5):510-2. PubMed ID: 22323742
    [Abstract] [Full Text] [Related]

  • 40. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
    Hayashi M, Abe K, Fujita M, Okai K, Takahashi A, Ohira H.
    Intern Med; 2018 Sep 01; 57(17):2451-2458. PubMed ID: 29607963
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.